122 related articles for article (PubMed ID: 38593754)
1. Frailty Influences the Relationship between the Soluble Receptor for Advanced Glycation-End Products and Mortality in Older Adults with Diabetes Mellitus.
Butcher L; Carnicero JA; Pérès K; Bandinelli S; García-García FJ; Rodriguez-Artalejo F; Rodriguez-Mañas L; Erusalimsky JD
Gerontology; 2024; 70(6):585-594. PubMed ID: 38593754
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of soluble Receptor for Advanced Glycation End-products (RAGE) are associated with a higher risk of mortality in frail older adults.
Butcher L; Carnicero JA; Gomez Cabrero D; Dartigues JF; Pérès K; Garcia-Garcia FJ; Rodriguez-Mañas L; Erusalimsky JD;
Age Ageing; 2019 Sep; 48(5):696-702. PubMed ID: 31211360
[TBL] [Abstract][Full Text] [Related]
3. Higher sRAGE Levels Predict Mortality in Frail Older Adults with Cardiovascular Disease.
Butcher L; Carnicero JA; Pérès K; Colpo M; Gomez Cabrero D; Dartigues JF; Bandinelli S; Garcia-Garcia FJ; Rodríguez-Mañas L; Erusalimsky JD;
Gerontology; 2021; 67(2):202-210. PubMed ID: 33477147
[TBL] [Abstract][Full Text] [Related]
4. Frailty phenotype and its association with all-cause mortality in community-dwelling Norwegian women and men aged 70 years and older: The Tromsø Study 2001-2016.
Langholz PL; Strand BH; Cook S; Hopstock LA
Geriatr Gerontol Int; 2018 Aug; 18(8):1200-1205. PubMed ID: 29808951
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
6. Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study.
Ebert H; Lacruz ME; Kluttig A; Simm A; Greiser KH; Tiller D; Kartschmit N; Mikolajczyk R
Exp Gerontol; 2020 Mar; 131():110815. PubMed ID: 31857132
[TBL] [Abstract][Full Text] [Related]
7. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
8. Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease.
Reichert S; Triebert U; Santos AN; Hofmann B; Schaller HG; Schlitt A; Schulz S
Atherosclerosis; 2017 Nov; 266():234-239. PubMed ID: 28864204
[TBL] [Abstract][Full Text] [Related]
9. Physical frailty and mortality risk in Japanese older adults.
Yuki A; Otsuka R; Tange C; Nishita Y; Tomida M; Ando F; Shimokata H
Geriatr Gerontol Int; 2018 Jul; 18(7):1085-1092. PubMed ID: 29608043
[TBL] [Abstract][Full Text] [Related]
10. The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
Atzeni IM; Al-Adwi Y; Doornbos-van der Meer B; Roozendaal C; Stel A; van Goor H; Gan CT; Dickinson M; Timens W; Smit AJ; Westra J; Mulder DJ
Front Immunol; 2023; 14():1189257. PubMed ID: 37409127
[TBL] [Abstract][Full Text] [Related]
11. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
12. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
Porter B; Arthur A; Savva GM
BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
[TBL] [Abstract][Full Text] [Related]
13. The Association of Frailty with Hospitalizations and Mortality among Community Dwelling Older Adults with Diabetes.
Ferri-Guerra J; Aparicio-Ugarriza R; Salguero D; Baskaran D; Mohammed YN; Florez H; Ruiz JG
J Frailty Aging; 2020; 9(2):94-100. PubMed ID: 32259183
[TBL] [Abstract][Full Text] [Related]
14. The impact of frailty on prolonged hospitalization and mortality in elderly inpatients in Vietnam: a comparison between the frailty phenotype and the Reported Edmonton Frail Scale.
Nguyen AT; Nguyen TX; Nguyen TN; Nguyen THT; Pham T; Cumming R; Hilmer SN; Vu HTT
Clin Interv Aging; 2019; 14():381-388. PubMed ID: 30863032
[TBL] [Abstract][Full Text] [Related]
15. Frailty, transition in frailty status and all-cause mortality in older adults of a Taichung community-based population.
Wang MC; Li TC; Li CI; Liu CS; Lin WY; Lin CH; Yang CW; Yang SY; Lin CC
BMC Geriatr; 2019 Jan; 19(1):26. PubMed ID: 30691410
[TBL] [Abstract][Full Text] [Related]
16. The effects of frailty and cognitive impairment on 3-year mortality in older adults.
Lee Y; Kim J; Chon D; Lee KE; Kim JH; Myeong S; Kim S
Maturitas; 2018 Jan; 107():50-55. PubMed ID: 29169580
[TBL] [Abstract][Full Text] [Related]
17. Frailty status among older critically ill patients with severe acute kidney injury.
Beaubien-Souligny W; Yang A; Lebovic G; Wald R; Bagshaw SM
Crit Care; 2021 Feb; 25(1):84. PubMed ID: 33632288
[TBL] [Abstract][Full Text] [Related]
18. Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.
Thomas MC; Woodward M; Neal B; Li Q; Pickering R; Marre M; Williams B; Perkovic V; Cooper ME; Zoungas S; Chalmers J; Hillis GS;
Diabetes Care; 2015 Oct; 38(10):1891-7. PubMed ID: 26253728
[TBL] [Abstract][Full Text] [Related]
19. The ability of three different models of frailty to predict all-cause mortality: results from the European Male Aging Study (EMAS).
Ravindrarajah R; Lee DM; Pye SR; Gielen E; Boonen S; Vanderschueren D; Pendleton N; Finn JD; Tajar A; O'Connell MD; Rockwood K; Bartfai G; Casanueva FF; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC; O'Neill TW;
Arch Gerontol Geriatr; 2013; 57(3):360-8. PubMed ID: 23871598
[TBL] [Abstract][Full Text] [Related]
20. Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer.
Zhou X; Lin N; Zhang M; Wang X; An Y; Su Q; Du P; Li B; Chen H
BMC Endocr Disord; 2020 Nov; 20(1):170. PubMed ID: 33187505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
